Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming
NCT ID: NCT04120714
Last Updated: 2024-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2020-01-06
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In PUIG, an individual loses control when gambling online. He/she typically spends 8 to 10 hours on this activity, sometimes without eating or sleeping. Usual obligations, such as school or work, or family obligations are neglected. PUIG can cause great psychological and social suffering. Neurological complications (epilepsy) and deaths (cardiac arrest) related to PUIG have also been reported. These situations are all the more dramatic because they often affect adolescents and young adults. In Asia, PUIG has become a public health problem. To date, no treatment has been validated for this disorder.
Non-invasive brain stimulation (NIBS) techniques can modulate neural activity in the dorsolateral prefrontal cortex (DLPFC). This modulation makes it possible to reduce addictive behaviours through different mechanisms (reduction of craving, impulsivity, and decision-making disorders). These techniques could be effective for PUIG.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of tDCS on Internet Game Addiction
NCT03347643
Effect of the Transcranial Direct Current Stimulation on the Dopaminergic Transmission in Healthy Subjects
NCT02402101
Targeted TDCS Intervention for Internet Gaming Disorder
NCT06759051
Brain Mechanism and Intervention of Executive-control Dysfunction Among Gambling Disorder
NCT06195995
The Effect of Repetitive Transcranial Magnetic Stimulation for Internet Gaming Disorder
NCT06634498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo tDCS group
Inactive tDCS
Placebo tDCS
inactive DC transcranial stimulation (delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation) for 10 to 30 minutes, during 5 sessions
Questionnaires
* visual analogue scale (VAS)
* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)
* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)
* Go-No go test
* HAM-D scale
* SF-12 quality of life scale
Active tDCS group
Active tDCS
Active tDCS
active D.C. transcranial stimulation (delivers a low current (1 to 2 mA)) for 10 to 30 minutes, during 5 sessions
Questionnaires
* visual analogue scale (VAS)
* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)
* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)
* Go-No go test
* HAM-D scale
* SF-12 quality of life scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active tDCS
active D.C. transcranial stimulation (delivers a low current (1 to 2 mA)) for 10 to 30 minutes, during 5 sessions
Placebo tDCS
inactive DC transcranial stimulation (delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation) for 10 to 30 minutes, during 5 sessions
Questionnaires
* visual analogue scale (VAS)
* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)
* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)
* Go-No go test
* HAM-D scale
* SF-12 quality of life scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient and/or parents who have given oral consent
* Patient with PUIG (DSM-5 criteria)
* Patient that is motivated and willing to reduce or stop internet gaming
Exclusion Criteria
* Patient with severe chronic psychiatric comorbidity (schizophrenia, paranoia, chronic hallucinatory psychosis) and bipolar disorder types I and II
* Patient with a gambling addiction
* Patient who has had a recent change (\< 1 month) in the prescription of psychotropic treatment
* Patient with an addiction to a psychoactive substance other than tobacco
* Patient receiving psychiatric care without consent or legal protection (guardianship, curatorship)
* Minor patient without parental consent for care
* Patient with severe heart, kidney, liver or lung failure
* Patient with a contraindication to the practice of tDCS: metal parts, medical devices implanted in the brain
* Pregnancy or breastfeeding in progress (negative pregnancy test)
* Patient unable to commit to a three-month follow-up
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de DIJON
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TROJAK 2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.